About Kozhnosys

About company

The company is developing its flagship device, CanScan, which is designed to detect breast cancer as early as stage 1.It will use the funds from BIRAC for testing the prototype and conducting a wider observational study of exhaled breath of breast cancer patients, said Jilma Peruvangat, founder and chief executive, Kozhnosys.